Catalyst Wire Dossier Catalyst Wire Dossier

Nyxol Eye Drops

· Ocuphire Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nyxol Eye Drops, covering 2025-06-03 to 2025-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia [Phase 3]

See pricing